Is AGMB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for AGMB. It does not provide personalized investment advice.

AGMB (AgomAb Therapeutics NV American Depositary Shares) Stock Analysis - Financials

AgomAb Therapeutics NV American Depositary Shares (AGMB) is a publicly traded the market company. As of August 7, 2026, AGMB trades at $13.61 with a market cap of $705.23M and a P/E ratio of 0.00. AGMB moved +1.70% today. Year to date, AGMB is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $8.75 to $17.82. Analyst consensus is strong buy with an average price target of $26.52. Rallies surfaces AGMB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are AGMB's key financials?

AGMB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. AGMB recently traded at $13.61. Market cap is $705.23M. P/E ratio is 0.00. Revenue is $0.

AGMB Key Metrics

Key financial metrics for AGMB
Metric	Value
Price	$13.61
Market Cap	$705.23M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$17.82
52-Week Low	$8.75
Volume	266.44K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

AGMB Analyst Consensus

3 analysts cover AGMB: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $26.52.

Common questions about AGMB

What are AGMB's key financials?: AGMB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. AGMB recently traded at $13.61. Market cap is $705.23M. P/E ratio is 0.00. Revenue is $0.
Is AGMB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for AGMB. It does not provide personalized investment advice.